The inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat

  • A. Depaulis
Conference paper
Part of the Journal of Neural Transmission book series (NEURAL SUPPL, volume 35)


A system exerting inhibitory control over generalized epilepsies and involving neurons from the substantia nigra has been described by several authors in experimental models of convulsive seizures. In the present study, the existence of such a control system governing absence epilepsy was investigated using models of non-convulsive seizures in the rat. Activation of the GABAergic neurotransmission within the substantia nigra by local injection of GABA agonists (muscimol, THIP) or an inhibitor of GABA degradation (gamma-vinyl GABA) suppresses generalized non convulsive seizures, whether they are genetically determined or induced by systemic injections of gamma-butyrolactone (100 and 200 mg/kg), pentylenetetrazole (20 mg/kg) or THIP (7.5 mg/kg). The ascending dopaminergic nigral output or the GABAergic fibres to the ventromedial thalamus are not critically involved in this control system. By contrast, the GABAergic nigro-collicular pathway appears crucial: bilateral lesion of the superior colliculus abolishes the anti-epileptic effects of intranigral injection of muscimol and blockade of the GABAergic transmission within the superior colliculus results in a suppression of generalized non-convulsive seizures. Finally, activation of collicular cell bodies by low doses of kainic acid significantly suppresses absence seizures. These results suggest the existence of a control system inhibiting generalized non-convulsive seizures which is activated by the release of the tonic inhibition exerted by the nigral GABAergic fibres on collicular neurons. The similarities between this system and the control system described for convulsive seizures are discussed.


Substantia Nigra Superior Colliculus Absence Epilepsy Convulsive Seizure Audiogenic Seizure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Andén NE, Carlsson A, Dahlström A, Fuxe K, Hillarp NA, Larsson K (1984) Demonstration and mapping out of nigro-neostriatal dopamine neurons. Life Sci 3: 523–530CrossRefGoogle Scholar
  2. Bentivoglio M, Van der Kooy D, Kuypers HGJM (1979) The organization of the efférent projections of the substantia nigra in the rat. A retrograde fluorescent double labeling study. Brain Res 174: 1–17PubMedCrossRefGoogle Scholar
  3. Chevalier G, Thierry AM, Shibazaki T, Feger J (1981) Evidence for a GABAergic inhibitory nigro-collicular pathway in the rat. Neurosci Lett 21: 67–70PubMedCrossRefGoogle Scholar
  4. Chevalier G, Vacher S, Deniau JM, Desban M (1985) Disinhibition as a basic process in the expression of striatal functions. The striato-nigral influence on tecto-spinal/ tecto-diencephalic neurons. Brain Res 334: 215–226PubMedCrossRefGoogle Scholar
  5. Childs JA, Gale K (1983) Neurochemical evidence for a nigrotegmental GABAergic projection. Brain Res 258: 109–114CrossRefGoogle Scholar
  6. Dean P, Gale K (1989) Anticonvulsant action of GABA receptor blockade in the nigro-collicular target region. Brain Res 477: 391–395PubMedCrossRefGoogle Scholar
  7. Depaulis A, Vergnes M, Marescaux C, Lannes B, Warter JM (1988) Evidence that activation of GABA receptors in the substantia nigra suppresses spontaneous spike-and-wave discharges in the rat. Brain Res 448: 20–29PubMedCrossRefGoogle Scholar
  8. Depaulis A, Snead OC, III, Marescaux C, Vergnes M (1989) Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents. Brain Res 498: 64–72PubMedCrossRefGoogle Scholar
  9. Depaulis A, Liu Z, Vergnes M, Marescaux C, Micheletti G, Warter JM (1990a) Suppression of spontaneous generalized non-convulsive seizures in the rat by microinjection of GABA antagonists into the superior colliculus. Epilepsy Res 5: 192–198PubMedCrossRefGoogle Scholar
  10. Depaulis A, Marescaux C, Liu Z, Vergnes M (1990b) The GABAergic nigro-collicular pathway is not involved in the inhibitory control of audiogenic seizures in the rat. Neurosci Lett 111: 269–274PubMedCrossRefGoogle Scholar
  11. Depaulis A (1990c) Etude neuropharmacologique du contrôle inhibiteur par la substance noire des crises d’épilepsie généralisée non-convulsive chez le rat. Ph.D. dissertation, Louis Pasteur University, StrasbourgGoogle Scholar
  12. Depaulis A, Vergnes M, Liu Z, Kempf E, Marescaux C (1990d) Involvement of the nigral output pathways in the inhibitory control of the substantia nigra over generalized non-convulsive seizures in the rat. Neuroscience 39: 339–349PubMedCrossRefGoogle Scholar
  13. De Sarro G, Meldrum BS, Reavill C (1985) Anticonvulsant action of 2-amino-7- phosphonoheptanoic acid in the substantia nigra. Eur J Pharmacol 106: 175–179CrossRefGoogle Scholar
  14. Di Chiara G, Porceddu ML, Morelli M, Mulas ML, Gessa GL (1979) Evidence for a GABAergic projection from the substantia nigra to the ventromedial thalamus and to the superior colliculus of the rat. Brain Res 176: 273–284PubMedCrossRefGoogle Scholar
  15. Frye GD, McCown TJ, Breese GR (1983) Characterization of susceptibility to audiogenic seizures in ethanol-dependent rats after microinjection of gammaaminobutyric acid ( GABA) agonists into the inferior colliculus, substantia nigra and medial septum. J Pharmacol Exp Ther 227: 663–670PubMedGoogle Scholar
  16. Gale K (1985) Mechanisms of seizure control mediated by gamma aminobutyric acid: role of the substantia nigra. Fed Proc 44: 2414–2424PubMedGoogle Scholar
  17. Gale K, Iadarola MJ (1980) Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition. Science 208: 288–291PubMedCrossRefGoogle Scholar
  18. Garant DS, Gale K (1986) Intranigral muscimol attenuates electrographic signs of seizure activity induced by intravenous bicuculline in rats. Eur J Pharmacol 124: 365–369PubMedCrossRefGoogle Scholar
  19. Garant DS, Gale K (1987) Substantia nigra-mediated anticonvulsant actions: role of nigral output pathways. Exp Neurol 97: 143–159PubMedCrossRefGoogle Scholar
  20. Gonzalez LP, Hettinger MK (1984) Intranigral muscimol suppresses ethanol withdrawal seizures. Brain Res 298: 163–166PubMedCrossRefGoogle Scholar
  21. Grace AA, Bunney BS (1979) Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. Eur J Pharmacol 59: 211–218PubMedCrossRefGoogle Scholar
  22. Hopkins DA, Niessen LW (1976) Substantia nigra projections to the reticular formation, superior colliculus and central gray in the rat, cat and monkey. Neurosci Lett 2: 253–259PubMedCrossRefGoogle Scholar
  23. Iadarola MJ, Gale K (1982) Substantia nigra: site of anti-convulsant activity mediated by gamma-aminobutyric acid. Science 218: 1237–1240PubMedCrossRefGoogle Scholar
  24. Kilpatrick IC, Starr MS, Fletcher A, James TA, MacLeod NK (1980) Evidence for a GABAergic nigrothalamic pathway in the rat. I. Behavioral and biochemical studies. Exp Brain Res 40: 45–54PubMedCrossRefGoogle Scholar
  25. Lannes B (1989) Réflexion sur les relations entre maladie de Parkinson et Epilepsies. A propos des effets de lésions de neurones catécholaminergiques dans un modèle d’épilepsie généralisée non-convulsive du rat. Medical Doctorate dissertation, StrasbourgGoogle Scholar
  26. Le Gal La Salle G, Kaijima M, Feldblum S (1983) Abortive amygdaloid kindled seizures following microinjection of gamma-vinyl-GABA in the vicinity of substantia nigra in rats. Neurosci Lett 36: 69–74CrossRefGoogle Scholar
  27. Löscher W, Schwark WS (1985) Evidence for impaired GABAergic activity in the substantia nigra of amygdaloid kindled rats. Brain Res 339: 146–150PubMedCrossRefGoogle Scholar
  28. Löscher W, Czuczwar SJ, Jäkel R, Schwarz M (1987) Effect of microinjections of gamma-vinyl GABA or isoniazid into substantia nigra on the development of amydala kindling in rats. Exp Neurol 95: 622–638PubMedCrossRefGoogle Scholar
  29. McLeod NK, James TA, Kilpatrick IC, Starr MS (1980) Evidence for a GABAergic nigrothalamic pathway in the rat. II. Electrophysiological studies. Exp Brain Res 40: 55–61Google Scholar
  30. McNamara JO, Rigsbee JC, Galloway MT (1983) Evidence that substantia nigra is crucial to neural network of kindled seizures. Eur J Pharmacol 86: 485–486PubMedCrossRefGoogle Scholar
  31. Miller JW, McKeon AC, Ferrendelli JA (1987) Functional anatomy of pentylenetetrazol and electroshock seizures in the rat brainstem. Ann Neurol 22: 615–621PubMedCrossRefGoogle Scholar
  32. Mirski MA, McKeon AC, Ferendelli JA (1986) Anterior thalamus and substantia nigra: two distinct structures mediating experimental generalized seizures. Brain Res 397: 377–380PubMedCrossRefGoogle Scholar
  33. Moshé SL, Okada R, Albala BJ (1985) Ventromedial thalamic lesions and seizure susceptibility. Brain Res 337: 368–372PubMedCrossRefGoogle Scholar
  34. Mugnaini E, Oertel WH (1985) An atlas of the distribution of GAB Aergic neurons and terminals in the rat CNS as revealed by GAD immunohistochemistry. In: Björklund A, Hökfelt T (eds) Handbook of chemical neuroanatomy, vol IV. GABA and neuropeptides in the CNS. Elsevier, Amsterdam, pp 436–608Google Scholar
  35. Nitsch C, Okada Y (1976) Differential decrease of GABA in the substantia nigra and other discrete regions of the rabbit brain during the preictal period of methoxypyridoxine-induced seizures. Brain Res 105: 173–178PubMedCrossRefGoogle Scholar
  36. Okada R, Negishi N, Nagaya H (1989) The role of the nigrotegmental GABAergic pathway in the propagation of pentylenetetrazol-induced seizures. Brain Res 480: 383–387PubMedCrossRefGoogle Scholar
  37. Olsen RW, Wamsley JK, McCabe RT, Lee RJ, Lomax P (1985) Benzodiazepine/ gamma-aminobutyric acid receptor deficit in the midbrain of the seizure-susceptible gerbil. Proc Natl Acad Sci USA 82: 6701–6705PubMedCrossRefGoogle Scholar
  38. Paxinos G, Watson C (1982) The rat brain in stereotaxic coordinates. Academic Press, SydneyGoogle Scholar
  39. Platt K, Butler LS, Bonhaus DW, McNamara JO (1987) Evidence implicating alpha-2 adrenergic receptors in the anticonvulsant action of intranigral muscimol. J Pharmacol Exp Ther 241: 751–754PubMedGoogle Scholar
  40. Redgrave P, Dean P, Simkins M (1988) Intratectal glutamate suppresses pentylenetetrazole-induced spike-and-wave discharges. Eur J Pharmacol 158: 283–287PubMedCrossRefGoogle Scholar
  41. Sclafani A, Grossman SP (1969) Hyperphagia produced by knife cuts between the medial and lateral hypothalamus. Physiol Behav 4: 533–538CrossRefGoogle Scholar
  42. Siegel S (1956) Nonparametric statistics for the behavioral sciences. McGraw-Hill, New YorkGoogle Scholar
  43. Smith Y, Bolam JP (1989) Neurons of the substantia nigra reticulata receive a dense GABA-containing input from the globus pallidus in the rat. Brain Res 493: 160–167PubMedCrossRefGoogle Scholar
  44. Sperber EF, Wurpel JND, Zhao DY, Moshé SL (1989) Evidence for the involvement of nigral GABAA receptors in seizures of adult rats. Brain Res 480: 378–382PubMedCrossRefGoogle Scholar
  45. Toussi HR, Schatz RA, Waszczak BL (1987) Suppression of methionine sulfoximine seizures by intranigral gamma-vinyl GABA injection. Eur J Pharmacol 137: 261–264PubMedCrossRefGoogle Scholar
  46. Turski L, Cavalheiro EA, Schwarz M, Turski WA, De Moraes Mello EA, Bortolotto ZA, Klockgether T, Sontag K-H (1986) Susceptibility to seizures produced by pilocarpine in rats after microinjection of isoniazid or gamma-vinyl-GABA into the substantia nigra. Brain Res 370: 294–309PubMedCrossRefGoogle Scholar
  47. Unnerstall JR, Pizzi WJ (1981) Muscimol and gamma-hydroxybutyrate: similar interactions with convulsant agents. Life Sci 29: 337–344PubMedCrossRefGoogle Scholar
  48. Vergnes M, Marescaux C, Depaulis A, Micheletti G, Warter JM (1990a) Spontaneous spike and wave discharges in Wistar rats: a model of genetic generalized nonconvulsive epilepsy. In: Avoli M, Gloor P, Kostopoulos G, Naquet R (eds) Generalized epilepsy: cellular, molecular and pharmacological approaches. Birkhäuser, Boston, pp 238–253Google Scholar
  49. Vergnes M, Marescaux C, Depaulis A (1990b) Mapping of spontaneous spike and wave discharges in wistar rats with genetic generalized non-convulsive epilepsy. Brain Res 523: 87–91PubMedCrossRefGoogle Scholar
  50. Warter JM, Vergnes M, Depaulis A, Tranchant C, Rumbach L, Micheletti G, Marescaux C (1988) Effect of drugs affecting dopaminergic neurotransmission in rats with spontaneous petit mal-like seizures. Neuropharmacology 27: 269–274PubMedCrossRefGoogle Scholar
  51. Zhang H, Rosenberg HC, Tietz EI (1989) Injection of benzodiazepines but not GABA or muscimol into pars reticulata of substantia nigra suppresses pentylenetetrazol seizures. Brain Res 488: 73–79PubMedCrossRefGoogle Scholar
  52. Zhang H, Rosenberg HC, Tietz EI (1991) Anticonvulsant actions and interaction of GABA agonists and a benzodiazepine in pars reticulata of substantia nigra. Epilepsy Res 8: 11–20PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 1992

Authors and Affiliations

  • A. Depaulis
    • 1
  1. 1.Centre de Neurochimie du CNRSL.N.B.C.Strasbourg CedexFrance

Personalised recommendations